Coverage
-
October 22, 2026
A creditor of InvaTech Pharma Solutions is asking a New Jersey bankruptcy judge to reject the generic-drug developer's request to end its Chapter 11 case, saying it should be converted into a Chapter 7 liquidation instead.
4 other articles on this case.
View all »